Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)

Market Cap	4.94B +12.8%
Revenue (ttm)	2.68B -9.0%
Net Income	-303.26M
EPS	-0.30
Shares Out	992.30M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,909,605
Open	4.670
Previous Close	5.010
Day's Range	4.670 - 5.160
52-Week Range	4.470 - 10.270
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:300158

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, researches, develops, produces, and sells pharmaceutical drugs in China. The company offers drugs for oncology, dermatology, digestive, urological, and cardiovascular diseases, as well as seeds. It is also involved in the integrating seeds, seedling cultivation, planting, processing, storage; and provision of Chinese medicinal materials and processed medicinal slices. In addition, the company engages in the production of anti-tumor raw materials, small-volume injections, ly...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 3,695
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300158

Financial Performance

In 2025, SHE:300158's revenue was 2.78 billion, a decrease of -6.33% compared to the previous year's 2.97 billion. Losses were -301.06 million, -77.34% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error